西洛斯是一种有前途的免疫调节剂,可改善移植结果
Xianguo Li1, Zuojie Peng1, Ke An2
1Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Transplant immunology
|November 2, 2023
概括
西洛斯表现出显著的免疫抑制作用,通过抑制T细胞增殖和增强调节性T细胞,延长小鼠心脏全移植存活时间. 这种拉巴胺衍生物显示出减轻器官移植排斥的潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 移植生物学 移植生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 有效的免疫抑制对于预防器官移植排斥至关重要.
- 坦西罗利木斯是一种拉巴胺衍生物,正在研究其在移植中的免疫抑制潜力.
研究的目的:
- 在小鼠心脏全移植模型中评估temsirolimus的免疫抑制作用.
- 阐明西洛斯诱导的免疫抑制的潜在机制.
主要方法:
- 一个小鼠心脏全移植模型被利用.
- 进行了Temsirolimus的使用,移植生存评估,组织学和免疫学测试 (BrdU,流细胞计,ELISA,qPCR).
主要成果:
- 西洛 (20 mg/kg/day) 显著延长了移植的存活时间,并抑制了T细胞的增殖.
- 它降低了CD4+和CD8+T细胞数量,降低了抗体水平,调节了细胞因子 (增加IL-4,TGF-β;减少IFN-γ).
- 调控性T细胞 (Treg) 种群和Foxp3表达增加.
结论:
- 在器官移植中,Temsirolimus表现出强大的免疫抑制特性.
- 它代表了一种有前途的治疗候选物,用于预防移植体排斥.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
170
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
170
01:16Kidney Transplant III: Nursing Management
22
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
22
01:26Kidney Transplant II: Surgical Procedure
20
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
20
01:28Kidney Transplant I: Introduction
14
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
14
01:24Tissue Transplantation
376
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
376